LUBBOCK, TX (KCBD) - New concern about a different kind of drug shortage, one that could lead to a variety of serious problems later. The Infectious Diseases Society of America or IDSA says, compared to 25 years ago, we are currently facing a 75% decrease in the production of antibiotics. Especially now with the effort to mass produce vaccines against the flu, most drug companies are not actively looking for new antibiotics, since it can take nearly two billion dollars just to get that new drug approved.
"Even if they were to bring a product into the pipeline, which usually takes five to seven years to fruition, by the time that antibiotic is mature and ready to be approved, the bacteria could already be resistant to it," said Dr. Allan Morrison, an infectious disease specialist.
Dr. Morrison adds another reason drug makers are not looking for new antibiotics, they're not as profitable as lifestyle drugs that are bringing in big money, like expensive medications for erectile dysfunction or depression.
©2009 KCBD NewsChannel 11. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.